Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nuvation Bio Inc. Class A Common Stock (NY:NUVB)

5.416 -0.044 (-0.81%)
Streaming Delayed Price Updated: 9:37 AM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nuvation Bio Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction
From Nuvation Bio Inc.
Via Business Wire
News headline image
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading. 
Via Benzinga
Topics Stocks
News headline image
Analyst Expectations for Nuvation Bio's Future ↗
 
Via Benzinga
News headline image
Where Nuvation Bio Stands With Analysts ↗
 
Via Benzinga
News headline image
After FDA Hold, Nuvation Bio Stops NUV-422 Cancer Development Program ↗
 
Via Benzinga
News headline image
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors
From Nuvation Bio Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
Biotech’s Role in Addressing the Pancreatic Cancer Emergency
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Announces Departure of Chief Financial Officer
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio And 3 Other Stocks Under $4 Insiders Are Buying ↗
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board
From Nuvation Bio Inc.
Via Business Wire
News headline image
Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
News headline image
The 7 Worst Stocks to Buy Now ↗
With the market reeling from the banking crisis, even hardened gamblers should avoid these worst stocks to buy now. 
Via InvestorPlace
News headline image
Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗
 
Via Benzinga
News headline image
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868
From Nuvation Bio Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 64 companies achieved new lows for the year. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga
News headline image
Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
News headline image
Netflix Price Target Cut By This Analyst, Plus Morgan Stanley Predicts $403 For McKesson ↗
UBS cut the price target for Coupa Software Incorporated (NASDAQ: COUP) from $84 to $76. Coupa Software shares fell 4.9% to $64.44 in pre-market trading. 
Via Benzinga
News headline image
Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update
From Nuvation Bio Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday's session saw 51 companies set new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 92 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.